Hearing loss company Acousia Therapeutics to present key learnings and data from lead development programs at US and European meetings in August and September
(Adnkronos) – TÜBINGEN, Germany, Aug. 23, 2023 /PRNewswire/ — Acousia Therapeutics GmbH to sharekey learningsand data from its lead candidate development programs — clinical stage ACOU085 and late preclinical stage ACOU082 —
